Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Randomized, Open-Label Study Comparing the Safety and Efficacy of a Raltegravir Based NRTI Sparing Regimen

NCT00814879 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT00814879
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00814879 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Randomized, Open-Label Study Comparing the Safety and Efficacy of a Raltegravir Based NRTI Sparing Regimen
Lead sponsor
Yale University
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2009
Completion date
November 30, 2013
Enrollment
60 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

acquired immune deficiency syndrome, aids, hiv infections, human immunodeficiency virus